Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 2, 2026 · Investor press release · Financial statements
INTELLIGENT BIO SOLUTIONS INC.
7
Investor press release
Jun 2, 2026
| ItemItem | Disclosure |
|---|---|
| Item 7.01 | Regulation FD disclosure (investor press release or presentation) |
| Item 9.01 | Financial statements and exhibits |
INTELLIGENT BIO SOLUTIONS INC. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. 1 Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug Screening System Company expects to complete enrollment and data collection by the end of July, 2026 NEW YORK, June 02, 2026 – Intelligent Bio…
The filing reports Items 7.01, 9.01. None of these codes are typically workforce-tagged, but analysts still review them for indirect labor-market signals.
INTELLIGENT BIO SOLUTIONS INC. filed this 8-K with the SEC. cutoffs links it to the employer's layoff history, visa filings, and other labor-market signals.
